Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs.

ABSTRACT:

Background

Using data from a randomized trial, we evaluated the cost of HCV care facilitation that supports moving along the continuum of care for HIV/HCV co-infected individuals with substance use disorder.

Methods

Participants were HIV patients residing in the community, initially recruited from eight US hospital sites. They received HCV care facilitation (n = 51) or treatment as usual (n = 62) for up to six months. We used micro-costing methods to evaluate costs from the healthcare sector and patient perspectives in 2017 USD. We conducted sensitivity analyses varying care facilitator caseloads and examined offsetting savings using participant self-reported healthcare utilization.

Results

The average site start-up cost was $6320 (site range: $4320-$7000), primarily

SUBMITTER: Gutkind S 

PROVIDER: S-EPMC9238179 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature